Childhood onset nexilin dilated cardiomyopathy: A heterozygous and a homozygous case.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
08 2021
Historique:
revised: 03 03 2021
received: 09 11 2020
accepted: 05 04 2021
pubmed: 6 5 2021
medline: 13 1 2022
entrez: 5 5 2021
Statut: ppublish

Résumé

Pathogenic heterozygous NEXN variants are associated with progressive dilated cardiomyopathy (DCM) usually presenting around 50 years of age. We describe an asymptomatic boy who had transient DCM at 3 months of age, that resolved by 4 months. Presently, at 11 years of age, he has normal cardiac function with signs of mild DCM on cardiac MRI. Genetic diagnostics revealed a paternally derived, heterozygous 1949_1951del class 4 variant in NEXN. His father had mild DCM with mildly reduced systolic function. The second patient presented with fetal hydrops at 33 weeks gestation requiring emergency caesarian delivery. Postnatally she required ventilation and continuous inotropic support for left ventricle systolic dysfunction. She died after 2 weeks when therapy was withdrawn. Homozygous c.1174C > T,p.(R392*) class 4 variants in the NEXN gene were found via WES. Microscopic investigation showed endomyocardial fibroelastosis. Her parents, both heterozygous carriers, had normal cardiac function and the family history was normal. These patients show a new clinical spectrum of pediatric cardiac disease seen in heterozygous and homozygous NEXN variants, ranging from mild, transient DCM to a severe, fatal neonatal DCM. These patients support the inclusion of the NEXN gene in the investigation of pediatric patients with DCM, even in cases with transient DCM.

Identifiants

pubmed: 33949776
doi: 10.1002/ajmg.a.62231
pmc: PMC8359989
doi:

Substances chimiques

Microfilament Proteins 0
NEXN protein, human 0

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2464-2470

Informations de copyright

© 2021 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.

Références

Cardiol Young. 2019 Oct;29(10):1257-1263
pubmed: 31477192
PLoS One. 2017 Dec 18;12(12):e0189489
pubmed: 29253866
Cardiovasc Pathol. 2013 Sep-Oct;22(5):345-50
pubmed: 23518027
J Am Soc Echocardiogr. 2008 Aug;21(8):922-34
pubmed: 18406572
Pediatrics. 1998 Mar;101(3 Pt 1):369-76
pubmed: 9480999
J Am Coll Cardiol. 1998 Jan;31(1):186-94
pubmed: 9426039
Nat Med. 2009 Nov;15(11):1281-8
pubmed: 19881492
Am J Med Genet A. 2021 Aug;185(8):2464-2470
pubmed: 33949776
Eur Heart J. 2015 May 7;36(18):1123-35a
pubmed: 25163546
Basic Res Cardiol. 2016 Jan;111(1):6
pubmed: 26659360
Circulation. 2019 Jul 2;140(1):55-66
pubmed: 30982350
JAMA. 2006 Oct 18;296(15):1867-76
pubmed: 17047217

Auteurs

Luc Bruyndonckx (L)

Department of Pediatric Cardiology, Amsterdam University Medical Centers, Amsterdam, Netherlands.
Translational Research in Immunology and Inflammation, University of Antwerp, Antwerp, Belgium.

Judith L Vogelzang (JL)

Department of Neonatology, Amsterdam University Medical Centers, Amsterdam, Netherlands.

Marianna Bugiani (M)

Department of Pathology, Amsterdam University Medical Centers, Amsterdam, Netherlands.

Bart Straver (B)

Department of Pediatric Cardiology, Amsterdam University Medical Centers, Amsterdam, Netherlands.

Irene M Kuipers (IM)

Department of Pediatric Cardiology, Amsterdam University Medical Centers, Amsterdam, Netherlands.

Wes Onland (W)

Department of Neonatology, Amsterdam University Medical Centers, Amsterdam, Netherlands.

Eline A Nannenberg (EA)

Department of Clinical Genetics, Amsterdam University Medical Centers, Amsterdam, Netherlands.

Sally-Ann Clur (SA)

Department of Pediatric Cardiology, Amsterdam University Medical Centers, Amsterdam, Netherlands.

Saskia N van der Crabben (SN)

Department of Clinical Genetics, Amsterdam University Medical Centers, Amsterdam, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH